Israel's Teva Pharmaceutical Industries Ltd, which is the world's largest generic drug maker, announced on Wednesday that they have received final approval from the U. S. Food and Drug Administration, FDA for their Abbreviated New Drug Application, or ANDA, to market the generic version of acne drug Solodyn or Minocycline HCl, Extended-Release Tablets, 45 mg, 90 mg and 135 mg.